Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma

BACKGROUND: Chemo-resistance in hepatocellular carcinoma (HCC) is a major problem, and acquired drug resistance prevents cancer therapies from achieving complete responses. Molecular targeting therapy presents an opportunity to impede tumor through combination or sequential therapy, while the accura...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xia, Song, Ge, Xu, Zihan, Bu, Yang, Chang, Fan, Jia, Fengan, Xiao, Xuelian, Ren, Xuejiao, Zhang, Mei, Jia, Qingan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958774/
https://www.ncbi.nlm.nih.gov/pubmed/31931755
http://dx.doi.org/10.1186/s12885-019-6480-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958774/
https://www.ncbi.nlm.nih.gov/pubmed/31931755
http://dx.doi.org/10.1186/s12885-019-6480-9

Ejemplares similares